Navigation Links
Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer

Individuals with advanced-stage laryngeal cancer at diagnosis were more likely to be uninsured or covered by Medicaid than to have private insurance, according to a report in the August issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

Laryngeal [voice box] cancer is diagnosed in nearly 10,000 men and women in the United States annually and is among the most common cancers in the upper aerodigestive tract, according to background information in the article. Stage at diagnosis is a key factor influencing prognosis and treatment. It is plausible that individuals without health insurance or with other barriers to health care access would be less likely to seek medical attention for these symptoms and thus present at a later stage with worse survival and fewer options for treatment.

Amy Y. Chen, M.D., M.P.H., of Emory University and the American Cancer Society, Atlanta, and colleagues analyzed medical and insurance information from 61,131 patients diagnosed between 1996 and 2003 to examine the relationship between patients insurance status and overall stage of cancer and tumor size at diagnosis. Stage at diagnosis was categorized as early (stages I and II) or advanced (stages III and IV) and tumor size (T stage) at diagnosis was categorized as T1, T2, T3 or T4, with T4 being the largest. Patient race, sex, age, U.S. census region of residence, education and ZIP code as well as type of treatment facility were also noted.

There were 32,665 (53.4 percent) [patients] with early-stage disease and 28,466 (46.6 percent) with advanced-stage disease. The distribution of T stage included 22,693 (37.1 percent) with T1 disease, 15,111 (24.7 percent) with T2 disease, 13,541 (22.2 percent) with T3 disease and 9,786 (16 percent) with T4 disease, the authors write. Patients with advanced-stage disease or more advanced T stage were more likely to be uninsured or have Medicaid or other government-funded plans than were those with early-stage disease.

Patients who were female, black, between ages 18 and 56 or who live in ZIP codes with low proportions of high school graduates or with low median household incomes were more likely to be diagnosed with an advanced stage of the disease and/or larger tumors. Those treated at teaching/research facilities were also more likely to have advanced disease.

In conclusion, our analyses provide the first assessment, to our knowledge, of the strong association between medical insurance and stage of laryngeal cancer at diagnosis among a large, generalizable cohort. Insurance coverage is a highly modifiable factor that affects not only tumor associated morbidity and mortality but also quality of life and economic costs, the authors conclude.


Contact: Becky Steinmark
JAMA and Archives Journals

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. HIV infected patients can travel safely abroad
7. New vaccine helps allergy and asthma patients
8. Doctors operate upon patients in candlelight- latest from the quake scene
9. New vaccine helps allergy and asthma patients
10. Are cancer patients being taken for a ride?
11. Alternative medicine more popular among HIV positive patients
Post Your Comments:
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: